Literature DB >> 11414553

Addressing an idiosyncrasy in estimating survival curves using double sampling in the presence of self-selected right censoring.

C E Frangakis1, D B Rubin.   

Abstract

We investigate the use of follow-up samples of individuals to estimate survival curves from studies that are subject to right censoring from two sources: (i) early termination of the study, namely, administrative censoring, or (ii) censoring due to lost data prior to administrative censoring, so-called dropout. We assume that, for the full cohort of individuals, administrative censoring times are independent of the subjects' inherent characteristics, including survival time. To address the loss to censoring due to dropout, which we allow to be possibly selective, we consider an intensive second phase of the study where a representative sample of the originally lost subjects is subsequently followed and their data recorded. As with double-sampling designs in survey methodology, the objective is to provide data on a representative subset of the dropouts. Despite assumed full response from the follow-up sample, we show that, in general in our setting, administrative censoring times are not independent of survival times within the two subgroups, nondropouts and sampled dropouts. As a result, the stratified Kaplan-Meier estimator is not appropriate for the cohort survival curve. Moreover, using the concept of potential outcomes, as opposed to observed outcomes, and thereby explicitly formulating the problem as a missing data problem, reveals and addresses these complications. We present an estimation method based on the likelihood of an easily observed subset of the data and study its properties analytically for large samples. We evaluate our method in a realistic situation by simulating data that match published margins on survival and dropout from an actual hip-replacement study. Limitations and extensions of our design and analytic method are discussed.

Mesh:

Year:  2001        PMID: 11414553     DOI: 10.1111/j.0006-341x.2001.00333.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  28 in total

1.  Principal stratification in causal inference.

Authors:  Constantine E Frangakis; Donald B Rubin
Journal:  Biometrics       Date:  2002-03       Impact factor: 2.571

2.  A causal framework for understanding the effect of losses to follow-up on epidemiologic analyses in clinic-based cohorts: the case of HIV-infected patients on antiretroviral therapy in Africa.

Authors:  Elvin H Geng; David V Glidden; David R Bangsberg; Mwebesa Bosco Bwana; Nicholas Musinguzi; Denis Nash; John Z Metcalfe; Constantin T Yiannoutsos; Jeffrey N Martin; Maya L Petersen
Journal:  Am J Epidemiol       Date:  2012-02-03       Impact factor: 4.897

3.  Choosing profile double-sampling designs for survival estimation with application to President's Emergency Plan for AIDS Relief evaluation.

Authors:  Ming-Wen An; Constantine E Frangakis; Constantin T Yiannoutsos
Journal:  Stat Med       Date:  2014-01-10       Impact factor: 2.373

4.  Cohort Profile: the international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa.

Authors:  Matthias Egger; Didier K Ekouevi; Carolyn Williams; Rita Elias Lyamuya; Henri Mukumbi; Paula Braitstein; Tyler Hartwell; Claire Graber; Benjamin H Chi; Andrew Boulle; François Dabis; Kara Wools-Kaloustian
Journal:  Int J Epidemiol       Date:  2011-05-18       Impact factor: 7.196

5.  Marginal and Conditional Distribution Estimation from Double-Sampled Semi-Competing Risks Data.

Authors:  Menggang Yu; Constantin T Yiannoutsos
Journal:  Scand Stat Theory Appl       Date:  2015-03-01       Impact factor: 1.396

6.  Learning About Missing Data Mechanisms in Electronic Health Records-based Research: A Survey-based Approach.

Authors:  Sebastien Haneuse; Andy Bogart; Ina Jazic; Emily O Westbrook; Denise Boudreau; Mary Kay Theis; Greg E Simon; David Arterburn
Journal:  Epidemiology       Date:  2016-01       Impact factor: 4.822

7.  Failure to initiate antiretroviral therapy, loss to follow-up and mortality among HIV-infected patients during the pre-ART period in Uganda.

Authors:  Elvin H Geng; Mwebesa B Bwana; Winnie Muyindike; David V Glidden; David R Bangsberg; Torsten B Neilands; Ingrid Bernheimer; Nicolas Musinguzi; Constantin T Yiannoutsos; Jeffrey N Martin
Journal:  J Acquir Immune Defic Syndr       Date:  2013-06-01       Impact factor: 3.731

8.  Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa.

Authors:  Elvin H Geng; Nneka Emenyonu; Mwebesa Bosco Bwana; David V Glidden; Jeffrey N Martin
Journal:  JAMA       Date:  2008-08-06       Impact factor: 56.272

9.  Adjusting mortality for loss to follow-up: analysis of five ART programmes in sub-Saharan Africa.

Authors:  Martin W G Brinkhof; Ben D Spycher; Constantin Yiannoutsos; Ralf Weigel; Robin Wood; Eugène Messou; Andrew Boulle; Matthias Egger; Jonathan A C Sterne
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

10.  Differential losses to follow-up that are outcome-dependent can vitiate a clinical trial: Simulation results.

Authors:  Richard F Potthoff
Journal:  J Biopharm Stat       Date:  2017-10-30       Impact factor: 1.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.